Healthy Measures

Making sense of patient data - to upgrade Europe’s health systems

Health transformations:
How smarter use of data can improve health and wellbeing – and stimulate the economy

23 May 2017, Aalto University, Otaniemi Campus, Auditorium B , Espoo, Finland

Programme
9:30 - Welcome
By Richard L. Hudson, Editor-in-chief & Vice Chair of the Board, Science|Business

9:35 - Opening addresses

The Finnish health transformation:

• Pirkko Mattila, Minister of Social Affairs and Health, Finland
Introduced by: Tuula Teeri, President, Aalto University

The EU perspective:
• Xavier Prats Monné, Director General, DG Health and Food Safety, European Commission
Introduced by: Pekka Soini, Director General, Tekes - The Finnish Funding Agency for Innovation

10:15 - Why e-health data?

Panel discussion on the benefits – to patients, entrepreneurs and society – of making better use of health
data.

• Ilkka Niemelä, Provost, Aalto University

• Corinne Le Goff, Senior Vice President, Europe, Amgen
• Pirkko Mattila, Minister of Social Affairs and Health, Finland
• Xavier Prats Monné, Director General, DG Health and Food Safety, European Commission
• Pekka Soini, Director General, Tekes - The Finnish Funding Agency for Innovation

Moderator: Richard L. Hudson, Editor-in-chief & Vice Chair of the Board, Science|Business

Supported by Hosted by
 Programme

11:15 - Break

11:45 - Case studies in building health ecosystems

Showcasing best practice in how health data can spark the growth of dynamic innovation clusters:

• Tuula Palmén, Head of Project Office, Health Capital Helsinki

• Andres Metspalu, Director, The Estonian Genome Center, University of Tartu
• Visa Honkanen, Director, Helsinki University Hospital
• Jani Ahonala, CEO, Noona Healthcare

Moderator: Mirja Kaarlela, Director, Large Companies and Public Organisations, Tekes - The Finnish
Funding Agency for Innovation

12:45 - Lunch

13:45 - The health data challenge

The biggest benefits will come from making better use of data on patient outcomes, but what systems and
treatments work best? A discussion of the challenges and opportunities.

• Ian Forde, Senior Policy Analyst, OECD Health Division

• Cornelius Schmaltz, Head of Unit for Strategy, E-Health, DG Research and Innovation, European
Commission
• Samuel Kaski, Director, Finnish Centre of Excellence in Computational Inference Research (COIN);
Professor, Computer Science, Aalto University
• Olli Carpén, Scientific Director, Helsinki Biobank

Moderator: Petri Lehto, Director, Policy and Communication, MSD Finland Oy

14:45 - The way ahead: How to make better use of data – for health and prosperity

• Paul Lillrank, Professor, Quality and Service Management, Aalto University

• Tuomas Poskiparta, Partner, Nightingale Health
• Mikko Leino, Partner, M&M Growth Partners
• Gail Kent, Director, Resources and Support, DG Communications, Networks, Content & Technology,
European Commission
• Arne Köhler, Principal, The Boston Consulting Group

Moderator: Maryline Fiaschi, Managing Director, Science|Business

16:00 - Networking reception

One-on-one networking app #healthyhelsinki

from brella.io
 Speakers

Jani Ahonala
CEO, Noona Healthcare

Jani Ahonala is the co-founder and chairman of the board of Noona Healthcare. During the
past 15 years, Ahonala has worked as a researcher, healthcare management consultant and
entrepreneur. He has worked with many of the leading hospitals around the world and been an
adviser for pharmaceutical companies, helping them adopt service-centred business models
and digital solutions. During his career as managing director at the design agency Kaufmann,
Ahonala was focused on the development of more customer- centred services, especially within
cancer care. Together with his colleagues he went on to found Noona Healthcare – the start-up
behind mobile service Noona, which helps cancer centres monitor the recovery of their patients
and reallocate resources to where they are needed most.

Olli Carpén
Scientific Director, Helsinki Biobank

Olli Carpén is professor of pathology at the University of Helsinki and scientific director at Helsinki
biobank. He studied medicine at the University of Helsinki and continued his studies at Harvard
Medical School. After returning to Finland, he specialised in pathology and in 2004 was elected
as a professor of pathology at the University of Turku. Carpén has been active in creating the
Finnish biobank network, and providing expertise within the international biobank community.
He is passionate about implementing biobanking into health care and personalised medicine
research. His additional research interest is cancer, especially mechanisms of chemoresistance
and the discovery of prognostic and predictive biomarkers.

Maryline Fiaschi
Managing Director, Science|Business

Maryline Fiaschi combines expertise in media, communications and European affairs. After six
years managing EU education programmes with the European Commission, Fiaschi entered the
media business in 2007 in Shanghai. She held business development positions at the Shanghai
Daily and EU affairs media company EurActiv before joining Science|Business in 2011 where
she now leads the company’s operations and growth strategy. She is also an external evaluator
for several EU higher education and R&I programmes. Fiaschi holds degrees from Université La
Sorbonne, Università di Bologna and Université catholique de Louvain.

Ian Forde
Senior Policy Analyst, OECD Health Division

Ian Forde is a senior policy analyst in the health division at the OECD. He co-ordinates a series
of reviews of health care quality across OECD countries and leads the health division’s work
on primary care in the Latin America region. He has previously worked as a policy advisor in
the Ministry of Health, Bogotá, and in the Prime Minister’s strategy unit in London. Forde also
maintains work as a general practitioner in London. He has a degree in social and political
science from Cambridge University, in Medicine from Oxford University, and a PhD from
University College London, examining the health impacts of welfare reform in Colombia.
 Speakers

Visa Honkanen
Director Strategic Development, Helsinki University Hospital

Since 2013, Visa Honkanen has served as director of the Helsinki University Hospital, a centre
that provides care for more than 1.5 million people. From 2006 to 2013 he worked for UCB,
first as medical director for Scandinavia and then for Northern Europe. Honkanen is focused
on eHealth and digitalisation and to bringing machine learning to the daily work of health care
professionals.

Richard Hudson
Editor-in-chief & Vice Chair of the Board, Science|Business

Rich has been a leading science and technology journalist in Europe for more than 30 years. As
managing editor of The Wall Street Journal Europe from 1997 to 2003, he helped lead a redesign
of the title in 2000. He co-founded Science|Business in 2004. He is also co-author of book with
Yale/IBM “fractal” mathematician Benoit Mandelbrot: “The (mis)Behavior of Markets: A fractal
view of risk, ruin & reward”: Basic Books 2004. He is a graduate of Harvard, and a former Knight
Fellow at MIT.

Mirja Kaarlela
Director, Large Companies and Public Organisations, Tekes - The Finnish Funding Agency for
Innovation

Mirja Kaarlela is currently responsible for Tekes’ strategy in health and wellbeing. She has a
long and diverse experience working in various innovation environments in both private and
public sectors, in Finland and in the US. Kaarlela’s experience includes all aspects of innovation
from evaluation and funding to strategic prioritization within private and public domains. She is
passionate about global collaboration, open communication and understanding the changing
innovation dynamics.

Samuel Kaski
Director, Finnish Centre of Excellence in Computational Inference Research (COIN); Professor,
Computer Science, Aalto University

Samuel Kaski is a researcher and professor of computer science at Aalto University, and
director of the Finnish Centre of Excellence in Computational Inference Research. Previously, he
directed the Helsinki Institute for Information Technology and was a professor at the University of
Helsinki. Kaski is an editor at two top ranking machine learning journals, The Journal of Machine
Learning Research and IEEE Transactions on Pattern Analysis and Machine Intelligence. His
field is probabilistic machine learning, with applications involving multiple data sources in health
and biology, user interaction, and data visualisation. He has published over 200 peer-reviewed
papers.

Gail Kent
Director, Resources and Support, DG Communications, Networks, Content & Technology,
European Commission

Gail Kent is currently director of resources in the European Commission’s Directorate-General

Connect. In 2016 she was also the acting deputy director general for the directorate in charge
of ICT research. In her current role she is responsible for a budget of €1.6bn a year and 1,000
staff. Kent has over 20 years of experience in the European Commission across several DGs,
managing large budgets, finance, compliance and HR in a multi-lingual, multi-cultural, highly
political environment. Prior to joining the Commission, she spent 10 years working in product
management and merchandising for several retail companies in the UK.
 Speakers

Arne Köhler
Principal, The Boston Consulting Group

Arne Köhler is part of The Boston Consulting Group’s (BCG) Nordic Health Care leadership
team and he leads BCG’s Health Care work in Finland. Together with Harvard Business School,
Michael Porter and Karolinska Institutet of Sweden, BCG founded ICHOM, an independent not-
for-profit focused on defining standard metrics for outcome quality for different patient groups.
BCG is currently working with the World Economic Forum on how to transition health care
systems towards a more value focused health care.

Corinne Le Goff
Senior Vice President, Europe, Amgen

Corinne M. Le Goff has been the senior vice president and regional general manager of Amgen
Inc. since 2015, where she is the head of Amgen’s European Region. Before joining Amgen, Le
Goff was president of Roche S.A.S, following five years in strategic commercial leadership roles
managing large therapeutic areas at both Roche, where she was senior vice president of Global
Product Strategy for the Neurosciences franchise, and at Merck Serono, where she was senior
vice president of Strategy and Global Marketing for Neurology, Rheumatology, and Immunology.
Prior to Merck Serono, Le Goff was senior vice president of U.S. Commercial Operations
Empowered Regions at Sanofi-Aventis. Le Goff received a Pharm. D. from the University Paris
V and an MBA in marketing from La Sorbonne University, France.

Petri Lehto
Director, Policy and Communication, MSD Finland Oy

Petri Lehto works at the pharmaceutical company MSD as a director for policy and
communications. Prior to this, he worked for many years at the Ministry of Economic Affairs
and Employment and as a head of division responsible for innovation policy. This included
participating in the working group which drafted the report for the health sector’s growth strategy
as well as developing demand and user driven innovation policy for Finland. He also worked
for a number of years as an industry counsellor for the permanent delegation of Finland to the
OECD in Paris. He has a Ph.D. in economics from the University of Turku and a Master’s degree
in economics from the Johns Hopkins University.

Mikko Leino
Partner, M&M Growth Partners

Mikko Leino has worked as an entrepreneur, CEO, board member and chairman for a number
of companies, including a leading Nordic value based healthcare solutions provider, Datawell
Group, which he founded 30 years ago. Mikko’s strengths are in digital health, analytics,
tech management, board work as well as strategy development and implementation. He was
awarded the Entrepreneur of the Year in Espoo in 2014.

Paul Lillrank
Professor, Quality and Service Management, Aalto University

Paul Lillrank has been professor of quality and service management at Aalto University since
1994. He has served as the head of the department of industrial engineering and management,
and as academic dean of the school’s MBA program. Lillrank received a Ph.D. in social sciences
at Helsinki University in 1988 after post-graduate studies in Japan. He then joined The Boston
Consulting Group in Tokyo, returning to academia in 1992 at the European Institute of Japanese
Studies at the Stockholm School of Economics. His research area is Healthcare Operations
Management. He has co-founded The Institute of Healthcare Engineering, Management and
Architecture (HEMA), and The Nordic Healthcare Group (NHG) Co.Ltd.
 Speakers

Pirkko Mattila
Minister of Social Affairs and Health, Finland

Pirkko Mattila is a politician and a member of the True Finns party. Since 2016, she has been the
Finnish Minister for Social Affairs and Health as well as member of the Finnish Parliament from
the constituency of Oulu since 2011. Mattila started her political career as vice chairman of the
municipal council (2009-12) and provincial ombudsman (2009-13). Prior to working in politics,
she worked as a nurse for almost 20 years and holds a Master’s Degree in cultural geography
from the University of Oulu.

Andres Metspalu
Director, The Estonian Genome Center, University of Tartu

Andres Metspalu is director of the Estonian Genome Center at the University of Tartu. Former
president of the European Society of Human Genetics, he was elected to the Estonian Academy
of Sciences in 2010; in this same year, he was also awarded doctor honoris causa from Vilnius
University. Metspalu obtained MD in 1976 and his PhD in molecular biology in 1979. His main
scientific interests are human genomics, genetics of complex diseases and population based
biobanks and application of precision medicine in health care. He has published over 350
papers.

Xavier Prats Monné

Director General, DG Health and Food Safety, European Commission

Xavier Prats Monné has been the Director General of the European Commission’s Directorate-
General for Health and Food Safety since September 2015. He previously served as Director
General for education and culture, and as director for employment policy. He holds degrees
in social anthropology from the Universidad Complutense (Madrid, Spain); in Development
Cooperation from the International Centre for Advanced Mediterranean Agronomic Studies
(Paris, France); and in European studies from the College of Europe (Bruges, Belgium), where
he graduated first of the Class of 1981-82 and served as assistant professor. He is from Spain
and is fluent in Spanish, English, French, Italian and Catalan.

Ilkka Niemelä
Provost, Aalto University

Ilkka Niemelä currently serves as the Provost of Aalto University. Prior to this, he served as deputy
president of Aalto University from 2012 to 2014 and as dean of the Aalto University School of
Science from 2011 to 2012. Niemelä’s current research interests include automated reasoning,
constraint programming, knowledge representation, computational complexity, computer
aided verification, automated testing and product configuration. He leads the computational
logic group and is one of the principal investigators of the Finnish Center of Excellence in
Computational Inference Research (COIN).

Tuula Palmén
Head of Project Office, Health Capital Helsinki

Tuula Palmén has been head of project office for Health Capital Helsinki since August 2015.
Between 2006 and 2015, she was responsible for the development of the life sciences at the
University of Oulu. Between 2003 and 2006 she led the Centre of Expertise for Medical and
Welfare Technologies in the Helsinki Metropolitan Region. Previously, she was a scientist at the
University of Helsinki. Palmén also has 10 years of business experience in the medical device
and diagnostic industry at KONE Corporation, Tamro Corporation and Immuno Diagnostics.
 Speakers

Tuomas Poskiparta
Partner, Nightingale Health

Tuomas Poskiparta is expert in setting up and running international business models, specialised
in operational performance, and commercialisation of innovations. Being an enthusiastic
entrepreneur, he is currently partnering in startups in the healthcare, financial asset management
and ICT sectors.

Cornelius Schmaltz
Head of Unit for Strategy, E-Health, DG Research and Innovation, European Commission

Cornelius Schmaltz has been an official at the European Commission’s Directorate-General for
Research and Innovation since 2006, where he is currently head of unit for strategy in health
research. He is the co-author of 11 original papers in peer-reviewed journals, including Nature
Medicine and Nature Genetics. Schmaltz received his MD and his training as a board-certified
paediatrician from the University of Freiburg, Germany. Following a postdoc at the Dana-Farber
Cancer Institute in Boston and a fellowship in Paediatric Haematology/Oncology at the Memorial
Sloan-Kettering Cancer Centre in New York, he joined the Volkswagen Foundation in Germany,
as programme manager in medicine.

Pekka Soini
Director General, Tekes - The Finnish Funding Agency for Innovation

Pekka Soini has been Director General and CEO of Tekes since 2012. Prior to his current
position, he headed the corporate development office at Nokia Siemens Networks and was
country director for Finland. Soini has nearly 30 years of experience in the internationalisation
of global corporations and various executive duties, as well as a broad range of experience
and knowledge in the business world. He is a member in several governmental and business
councils and boards.

Tuula Teeri
President, Aalto University

Tuula Teeri is the first President of Aalto University and has held the post since April 2009.
Under her leadership, Aalto has implemented the tenure track career system for professors,
renewed its educational offering and developed multidisciplinary research and educational
initiatives. During her scientific career, she was a pioneer of forest industrial biotechnology and
the development of biomimetic materials. Teeri has held research and leadership positions in a
range of universities and research institutes and this autumn takes on the role of president of
the Royal Swedish Academy of Engineering.
 Healthy Measures
Making sense of patient data - to upgrade Europe’s health systems

Partners

Aalto University
Amgen
Barcelona Supercomputing Center
ESADE Business School
GE Healthcare
Hospital St. Joan de Déu, Barcelona
International Consortium for Health Outcomes Measurement (ICHOM)
Karolinska Institutet
Merck Sharp & Dohme
Norwegian University of Science and Technology
Novartis
Politecnico di Milano
Sanofi
Tekes (Finnish Funding Agency for Innovation)
Université Pierre et Marie Curie
Warwick Medical School

Observers

European Commission
OECD Health Division

http://sciencebusiness.net/health

Follow @scibus